Facility #1

Winchester, Virginia 22601

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Breast Neoplasm

Studies at this site

• Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Combination With Pembrolizumab in Participants With Metastatic Triple-Negative Breast Cancer (mTNBC) — Completed
• Study to Evaluate the Efficacy and Safety of Eribulin Mesylate Administered Biweekly (Q2W) for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Metastatic Breast Cancer — Completed